Calorie labels cut intake slightly, but alcohol impact unclear

Physi­cians don’t hate pre­scrip­tion drug ads, they just want the pro­mo­tions to do more. That’s ac­cord­ing to Sy­neos Health’s most re­cent An­swer­Suite sur­vey of health­care

Xphozah’s approval was based on data from three Phase III clinical trials. Image Credit: Maxx-Studio / Shutterstock. The US Food and Drug Administration (FDA) approved

Pro­tara Ther­a­peu­tics rais­es $45M pri­vate place­ment: The over­sub­scribed fi­nanc­ing trans­ac­tion is set to close April 10. The pro­ceeds should ex­tend the com­pa­ny’s run­way through 2026